Announcements Trials
Browse Landscape

Phase

Phase 2 43Phase 3 23Phase 1 10Phase 2/3 8Phase 1/2 8Phase 4 3Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 10Unknown 5Active not recruiting 3Not yet recruiting 2Terminated 1Suspended 1Recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 2Plasma cell 1

Conditions

Prostatic Neoplasms, Castration-Resistant 1Prostatic Neoplasms 1Multiple Myeloma 1Metastatic Castration-resistant Prostate Cancer 1Dementia 1Cognitive Dysfunction 1

Interventions

Human Papillomavirus Recombinant Vaccine nonavalent 5Prednisone 3Dexamethasone 3Cisplatin 3Atorvastatin 3olaparib 2lorlatinib 2human papillomavirus vaccine, L1 type 16, 18 2enzalutamide 2adacel 2Tobacco Use Cessation Devices 2Tetanus Toxoid 2Papillomavirus Vaccines 2Letrozole 2Diphtheria-Tetanus-acellular Pertussis Vaccines 2Diphtheria Toxoid 2Denosumab 2Carboplatin 2Anesthesia, Epidural 2Abiraterone Acetate 2xiapex 1venetoclax 1tirbanibulin 1tenofovir alafenamide 1sofosbuvir-velpatasvir drug combination 1ruxolitinib 1ribociclib 1radium Ra 223 dichloride 1pembrolizumab 1pasireotide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Active not recruiting × Prednisone × Clear all
NCT05457257 2026-04-21

Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have BRCA1/2 Mutations

AstraZeneca

Phase 4 Active not recruiting
43 enrolled 16 charts
Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT03016741 2026-02-24

Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer

Northwestern University

Phase 4 Active not recruiting
100 enrolled
Genitourinary

Dementia, Prostatic Neoplasms, Cognitive Dysfunction, Prostatic Neoplasms, Castration-Resistant

NCT03829371 2025-12-03

STUDY COMPARING TWO STANDARD TREATMENTS IN AUTOLOGOUS STEM CELL TRANSPLANTATION INELIGIBLE POPULATION AFFECTED BY MULTIPLE MYELOMA

University of Turin, Italy

Phase 4 Active not recruiting
450 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡